European temporal trends in the use of lymph node dissection in patients with renal cancer-Reference-Cited by-同舟云学术

European temporal trends in the use of lymph node dissection in patients with renal cancer

Published:2017-11 Issue:11 Volume:43 Page:2184-2192
ISSN:0748-7983
Container-title:European Journal of Surgical Oncology
language:en
Short-container-title:European Journal of Surgical Oncology

Author:

Capitanio U.^ORCID,Stewart G.D.,Larcher A.,Ouzaid I.,Akdogan B.,Roscigno M.,Marszalek M.,Dell'Oglio P.,Salagierski M.,Volpe A.,Mir M.C.,Kriegmair M.,Terrone C.,Brookman-May S.D.,Montorsi F.,Klatte T.

Publisher

Elsevier BV

Subject

Oncology,General Medicine,Surgery

Reference19 articles.

1. EAU guidelines on renal cell carcinoma: 2014 update;Ljungberg;Eur Urol,2015

2. NCCN guidelines – kidney cancer,2015

3. Renal cancer;capitanio;Lancet,2016

4. A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma;Van Poppel;Eur Urol,2011

5. Nephron-sparing techniques independently decrease the risk of cardiovascular events relative to radical nephrectomy in patients with a T1a-T1b renal mass and normal preoperative renal function;capitanio;Eur Urol,2015

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of lymphadenectomy during primary surgery for kidney cancer;Current Opinion in Urology;2023-04-10

2. How to optimize the use of adjuvant pembrolizumab in renal cell carcinoma: which patients benefit the most?;World Journal of Urology;2022-09-20

3. Potential benefit of lymph node dissection during radical nephrectomy for kidney cancer: A review and critical analysis of current literature;Asian Journal of Urology;2022-07

4. Re: Toni K. Choueiri, Piotr Tomczak, Se Hoon Park, et al. Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma. N Engl J Med 2021;385:683–94;European Urology;2022-01

5. Lymph node dissection during radical nephrectomy: A Canadian multi-institutional analysis;Urologic Oncology: Seminars and Original Investigations;2021-06